Subclinical basal cell carcinoma

1. AI-assisted line-field confocal optical coherence tomography predicts subclinical basal cell carcinoma in humans (83.3% (95% CI, 58.1%-96.4%)).

   “corresponding to a PPV of 83.3% (95% CI, 58.1%-96.4%)”

   Human trialinconspicuous facial skin in high-risk patientsskinn = 150

   AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma

   JAMA dermatology·19 Aug 2026

More on AI-assisted line-field confocal optical coherence tomography